BELINDA FERGUSON: Open Payments
NPI 1679230981 · WOODSTOCK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,196 in 82 payments from 16 companies in 2025. Trend: 2023 $883 · 2024 $812 · 2025 $2,196
Food & beverage: $2,067Education: $129
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $471 |
| GENZYME CORPORATION | 12 | $383 |
| GlaxoSmithKline, LLC. | 13 | $277 |
| Novartis Pharmaceuticals Corporation | 10 | $191 |
| Regeneron Healthcare Solutions, Inc. | 3 | $151 |
| BioCryst US Sales Co., LLC | 5 | $139 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $90 |
| Amgen Inc. | 3 | $83 |
| CSL Behring | 2 | $65 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, ORLADEYO, NEFFY, AIRSUPRA, Rhapsido, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
